Jun 3, 2026 8:28 AM
Faron Pharmaceuticals Limited (AIM:FARN) has repaid €1.6 million of debt owed to its convertible bondholder by issuing 3.4 million new shares rather than paying cash. New shares were issued for €0.4741 per share. They are due to begin trading on AIM and Nasdaq First North on 4…
Faron Pharmaceuticals Limited (AIM:FARN) has repaid €1.6 million of debt owed to its convertible bondholder by issuing 3.4 million new shares rather than paying cash. New shares were issued for €0.4741 per share. They are due to begin trading on AIM and Nasdaq First North on 4 June.
Comments
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy